Home» Medical News

FDA approves Inlyta to treat patients with a type of advanced kidney cancer
Views: 493
Date: 29 Jan 2012
Definition of medical terminology for Food.
Definition of medical terminology for Drug Administration Route.
Definition of medical terminology for Patients.
Definition of medical terminology for Kidney Cancer.
The U.S. Food and Drug Administration approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.

Definition of medical terminology for Kidney Cancer.
Definition of medical terminology for Kidney Bean.
Definition of medical terminology for Proteins.
Definition of medical terminology for Kinases.
Definition of medical terminology for Play.
Definition of medical terminology for Role.
Definition of medical terminology for Tumor.
Definition of medical terminology for Progression Free Survival.
Definition of medical terminology for Patients.
Definition of medical terminology for Hematology.
Definition of medical terminology for Drug Evaluation.
Definition of medical terminology for Evaluation.
Definition of medical terminology for Research.
Definition of medical terminology for Patients.
Definition of medical terminology for Drugs.
Definition of medical terminology for Kidney Cancer.
Generic name for a monoclonal antibody anticancer drug.
Definition of medical terminology for Safety.
Definition of medical terminology for Patients.
Definition of medical terminology for Disease.
Definition of medical terminology for Measure.
Definition of medical terminology for Patient.
Definition of medical terminology for Progression-Free Survival.
Definition of medical terminology for Survival.
Definition of medical terminology for Patients.
Definition of medical terminology for High Blood Pressure.
Definition of medical terminology for Blood Pressure.
Definition of medical terminology for Voice.
Definition of medical terminology for Syndrome.
Definition of medical terminology for High Blood Pressure.
Definition of medical terminology for Blood Pressure.
Definition of medical terminology for Patients.
Definition of medical terminology for Bleeding.
Definition of medical terminology for Fatal Familial Insomnia.
Definition of medical terminology for Patients.
Definition of medical terminology for Brain.
Definition of medical terminology for Bleeding.

Renal cell carcinoma is a type of kidney cancer that starts in the lining of very small tubes in the kidney . Inlyta works by blocking certain proteins called kinases that play a role in tumor growth and cancer progression . Inlyta is a pill that patients take twice a day.

aThis is the seventh drug that has been approved for the treatment of metastatic or advanced kidney cell cancer since 2005,a said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDAas Center for Drug Evaluation and Research. aCollectively, this unprecedented level of drug development within this time period has significantly altered the treatment paradigm of metastatic kidney cancer, and offers patients multiple treatment options.a

Recently approved drugs for the treatment of kidney cancer include sorafenib (2005), sunitinib (2006), temsirolimus (2007), everolimus (2009), bevacizumab (2009) and pazopanib (2009).

The safety and effectiveness of Inlyta were evaluated in a single randomized, open-label, multi-center clinical study of 723 patients whose disease had progressed on or after treatment with one prior systemic therapy. The study was designed to measure progression-free survival, the time a patient lived without the cancer progressing. Results showed a median progression-free survival of 6.7 months compared to 4.7 months with a standard treatment (sorafenib).

The most common side effects observed in greater than 20 percent of patients in the clinical study were diarrhea, high blood pressure (hypertension), fatigue, decreased appetite, nausea, loss of voice (dysphonia), hand-foot syndrome (palmar-plantar erythrodysesthesia), weight loss, vomiting, weakness (asthenia) and constipation.

Patients with high blood pressure should have it well-controlled before taking Inlyta. Some patients who took Inlyta experienced bleeding problems, which in some cases were fatal . Patients with untreated brain tumors or gastrointestinal bleeding should not take Inlyta.

Inlyta is marketed by New York City-based Pfizer Inc.


Source : DrugsFreeList.com
Tags: Inlyta, renal cell carcinoma, kidney cancer

Latest Medical News

» U.S. Food And Drug Administration Approves Pfizers INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
-Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved INLYTA (axitinib), a kinase inhibitor, for the treatment of patients with advanced renal cell carcinoma (RCC)
29 Jan 2012 | Read


» Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia
Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for standard review of bosutinib as a treatment option for adult patients with previously treated Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML).
29 Jan 2012 | Read


» FDA approves Inlyta to treat patients with a type of advanced kidney cancer
The U.S. Food and Drug Administration approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.
29 Jan 2012 | Read


» FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
The U.S. Food and Drug Administration (FDA) is informing the public that testing positive for anti-JC virus (JCV) antibodies has been identified as a risk factor for progressive multifocal leukoencephalopathy (PML).
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 27, 2012
New drugs approved. List of drugs approved by FDA to date January 27, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 26, 2012
New drugs approved. List of drugs approved by FDA to date January 26, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 25, 2012
New drugs approved.List of drugs approved by FDA to date January 25, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 24, 2012
New drugs approved. List of drugs approved by FDA to date January 24, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 23, 2012
New drugs approved.List of drugs approved by FDA to date January 23, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 20, 2012
New drugs approved. List of drugs approved by FDA to date January 20, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 19, 2012
New drugs approved. List of drugs approved by FDA to date January 19, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 18, 2012
New drugs approved. List of drugs approved by FDA to date January 18, 2012
29 Jan 2012 | Read


» FDA expands use of endovascular graft to treat aortic tears
The U.S. Food and Drug Administration expanded the approved usage for an endovascular graft manufactured by W.L. Gore and Associates Inc. to include treatment of life-threatening tears or ruptures of the aorta (thoracic aortic transection).
19 Jan 2012 | Read


» FDA approves Voraxaze to treat patients with toxic methotrexate levels
The U.S. Food and Drug Administration approved Voraxaze (glucarpidase) to treat patients with toxic levels of methotrexate in their blood due to kidney failure.
19 Jan 2012 | Read


» FDA Drug Safety Communication: New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin)
The U.S. Food and Drug Administration (FDA) is notifying the public that two additional cases of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection that can result in death, have been reported with the lymphoma drug Adcetris (brentuximab vedotin).
19 Jan 2012 | Read


General Search

Last medical tags:


Torisel, temsirolimus, Inlyta, chronic myeloid leukemia, bosutinib, Inlyta, renal cell carcinoma, kidney cancer, myelin, Tysabri, natalizumab, brain infection, progressive multifocal leukoencephalopathy, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, thoracic aortic transection, endovascular graft, methotrexate, Voraxaze, cancer chemotherapy drug, glucarpidase, Adcetris, bleomycin, multifocal leukoencephalopathy, CardioGen-82, radiation, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, raltegravir, Isentress, antiretroviral medicines, Theravance, Relovair, asthma, fluticasone, bronchitis, neuromuscular disease, SMA, muscle atrophy, Resolor, prokinetic, prucalopride, ADHD, psychiatric behavioural disorder, Venvanse, lisdexamfetamine dimesylate, type 2 diabetes mellitus, Actoplus Met XR, pioglitazone, Mylan, Eprosartan Mesylate Tablets, Teveten, antimicrobials, cephapirin, cephalosporin, teriflunomide, Rebif, alanine aminotransferase levels, flu-like symptoms, multiple sclerosis, electrical pulses, implantable pulse generator, Precision Plus Spinal Cord Stimulator, genetic blood clotting disorder, hemophilia A, Advate, bleeding episodes, heart failure, heart transplantation, Pediatric Medical Device Safety, pulsatile cardiac assist device, selective serotonin reuptake inhibitor, SSRI, pulmonary hypertension,
» All tags  
Sitemap